Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Temimed AB
AB
Active
Org 5566715925
Kallebäcksvägen 17 B, 412 75
Göteborg
Business and other management consultancy activities
· NACE 7020
Est. 2004
2 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Temimed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
189
278
535
356
317
Staff expenses
—
—
−10
−16
−12
EBITDA
115
192
462
243
234
Depreciation & amort.
−0
−0
—
—
—
EBIT
115
192
462
243
234
Net financials
—
—
0
8
11
Profit before tax
115
193
347
188
254
Tax
−27
−38
−71
−40
−54
Net profit
88
155
275
148
200
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
391
376
728
550
532
Equity
316
270
376
254
301
Long-term debt
0
0
—
—
—
Short-term debt
75
106
238
118
62
Total debt
75
106
238
118
62
Financial ratios
5-year trend
EBITDA margin
73.8%
This company
15.8%
Market median
+367% vs market
2021
2025
Equity ratio
56.5%
This company
38.2%
Market median
+48% vs market
2021
2025
Return on equity
66.5%
This company
18.4%
Market median
+261% vs market
2021
2025
Net profit margin
63.3%
This company
8.1%
Market median
+681% vs market
2021
2025
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
2021
2025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Temimed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network